MacMahon S, Rodgers A, Collins R, Farrell B. Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial. J Bone Joint Surg Br. 1994;76-B(4):521-524. doi:10.1302/0301-620X.76B4.8027132
MacMahon, S, et al. “Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial.”
The Journal of Bone & Joint Surgery British Volume, vol. 76-B, no. 4, 1994, pp. 521-524.,
https://doi.org/10.1302/0301-620X.76B4.8027132
MacMahon, S., Rodgers, A., Collins, R., & Farrell, B. (1994). Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial.
The Journal of Bone & Joint Surgery British Volume,
76-B(4), 521-524.
https://doi.org/10.1302/0301-620X.76B4.8027132
MacMahon, S., Rodgers, A., Collins, R. and Farrell, B. (1994) “Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial.”
The Journal of Bone & Joint Surgery British Volume, 76-B(4), pp. 521-524. Available at:
https://doi.org/10.1302/0301-620X.76B4.8027132
MacMahon, S, A Rodgers, R Collins, and B Farrell. “Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial.”
The Journal of Bone & Joint Surgery British Volume 76-B, no. 4 (1994): 521-524.
https://doi.org/10.1302/0301-620X.76B4.8027132
MacMahon S, Rodgers A, Collins R, Farrell B. Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial. J Bone Joint Surg Br. 1994 Jul 1;76-B(4):521-524.
https://doi.org/10.1302/0301-620X.76B4.8027132
